Skip to main content
. Author manuscript; available in PMC: 2022 Oct 26.
Published in final edited form as: Mol Cancer Ther. 2022 Mar 1;21(3):397–406. doi: 10.1158/1535-7163.MCT-21-0455

Figure 1.

Figure 1.

Structure of largazole-derivative OKI-006 and prodrugs OKI-005 and OKI-179. Largazole thiol was used a lead structure for medicinal chemistry optimization. Following identification of OKI-006, a first generation prodrug, OKI-005 was prepared and used for in vitro pharmacology studies. Subsequent prodrug optimization afforded OKI-179.